Recently, we reported that MPM cancer cells, characterized by the expression of Rb and cyclin D1 and negative for p16INK4a, were sensitive to the CDK4/6 inhibitor palbociclib, which induced a cell cycle blockade in the G0/G1 phase associated with cellular senescence. The gene discussed is CDK4; the disease is cancer.